New Hope 360

Most clinical research on an active ingredient is done under time constraint due to the high cost of clinical research. Thus, researchers often use high doses to achieve a measurable outcome. It is not necessarily advisable to  consume long-term the dose used in a short-term clinical trial. A smaller dose may very well not only be advisable from an efficacy point of view, but also from a safety point of view. Olav E. Sandnes, President, Marine Ingredients